The Times, They Are A-Changing: The Impact of Next-Generation Sequencing on Diagnosis, Classification, and Prognostication of Myeloid Malignancies With Focus on Myelodysplastic Syndrome, AML, and Germline Predisposition
American Society of Clinical Oncology Educational Book · 2023
DOI: 10.1200/edbk_390026 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Society of Clinical Oncology Educational Book, 2023. Verfasst von Sandeep Gurbuxani und 3 weiteren Autor:innen. Beteiligte Einrichtung: University of Chicago, Chicago, IL. Hauptthemen laut MEDLINE: Myelodysplastic Syndromes, Myeloproliferative Disorders, Hematologic Neoplasms, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben.
Abstract (Originalsprache)
Myeloid malignancies are a manifestation of clonal expansion of hematopoietic cells driven by somatic genetic alterations that may arise in a potential background of deleterious germline variants. As next-generation sequencing technology has become more accessible, real-world experience has allowed integration of molecular genomic data with morphology, immunophenotype, and conventional cytogenetics to refine our understanding of myeloid malignancies. This has prompted revisions in the classification and the prognostication schema of myeloid malignancies and germline predisposition to hematologic malignancies. This review provides an overview of significant changes in the recently published classifications of AML and myelodysplastic syndrome, emerging prognostic scoring, and the role of germline deleterious variants in predisposing to MDS and AML.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- University of Chicago, Chicago, IL.
- Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.
- Dana Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA.
Zitieren
APA
Gurbuxani, S., Hochman, M. J., DeZern, A. E., & Shimamura, A. (2023). The Times, They Are A-Changing: The Impact of Next-Generation Sequencing on Diagnosis, Classification, and Prognostication of Myeloid Malignancies With Focus on Myelodysplastic Syndrome, AML, and Germline Predisposition. American Society of Clinical Oncology Educational Book. https://doi.org/10.1200/edbk_390026
Vancouver
Gurbuxani S, Hochman MJ, DeZern AE, Shimamura A. The Times, They Are A-Changing: The Impact of Next-Generation Sequencing on Diagnosis, Classification, and Prognostication of Myeloid Malignancies With Focus on Myelodysplastic Syndrome, AML, and Germline Predisposition. American Society of Clinical Oncology Educational Book. 2023. doi:10.1200/edbk_390026
BibTeX
@article{Gurbuxani2023,
author = {Gurbuxani, Sandeep and Hochman, Michael J and DeZern, Amy E and Shimamura, Akiko},
title = {The Times, They Are A-Changing: The Impact of Next-Generation Sequencing on Diagnosis, Classification, and Prognostication of Myeloid Malignancies With Focus on Myelodysplastic Syndrome, AML, and Germline Predisposition},
journal = {American Society of Clinical Oncology Educational Book},
year = {2023},
doi = {10.1200/edbk_390026}
}
EUVIMED